ClinConnect ClinConnect Logo
Search / Trial NCT02504684

Treatment of Saphenous Vein Reflux With 1920-nm Diode Laser

Launched by INSTITUTO VASCULAR BH · Jul 20, 2015

Trial Information

Current as of April 29, 2025

Completed

Keywords

Varicose Veins Endovenous Laser Treatment Endovenous Thermal Ablation Saphenous Vein

ClinConnect Summary

INTRODUCTION The treatment of varicose veins secondary to saphenous vein reflux has undergone a major shift in the past decade, primarily led by the introduction of less invasive techniques. Wavelengths of 810, 940 and 980 nm have higher rates of absorption by hemoglobin. Water chromophore is associated with an initial energy absorption peak at 980 nm, followed by peaks at 1500 and 2000 nm. The energy released into the vein lumen is therefore absorbed by water as well as by cellular and interstitial proteins. In contrast, laser beams with longer wavelengths act more specifically on water ab...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with varicose veins associated with reflux of great or small saphenous veins
  • Exclusion Criteria:
  • Patients under 18 years old or over 70 years.
  • Acute or previous thrombophlebitis or deep vein thrombosis.
  • Pregnant patient.

About Instituto Vascular Bh

Instituto Vascular BH is a leading clinical research organization specializing in vascular health and innovative treatment methodologies. With a commitment to advancing medical knowledge and improving patient outcomes, the institute conducts rigorous clinical trials that adhere to the highest ethical and scientific standards. Utilizing state-of-the-art technology and a multidisciplinary team of experienced professionals, Instituto Vascular BH aims to contribute to the development of effective therapies and interventions in the field of vascular medicine. Their dedication to research excellence and patient care positions them as a trusted partner in the clinical research community.

Locations

Belo Horizonte, Minas Gerais, Brazil

Patients applied

0 patients applied

Trial Officials

Daniel M Pinto, MD

Principal Investigator

Instituto Vascular BH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials